Liver Cirrhosis Recruiting Phase 1 Trials for Sorafenib (DB00398)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02143401Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsTreatment